Edelteq unit in JV with Halo Technologies
The JV company, called Halovision System Sdn Bhd, will target applications in Substrate Panel (Raptor series) and semiconductor wafer Level (i-Falke series) inspection.
Edelteq and Halovision will each have a 50% share in the joint venture.
In a filing with Bursa Malaysia, Edelteq said the JV will provide a potential new income stream through profit-sharing from the JV company, with scalability across regional markets.
'The board believes that the proposed joint venture will contribute positively to the future performance and competitiveness of the Edelteq group. The proposed JV is not expected to have any material effect on the earnings per share, net assets per share, gearing, share capital and the substantial shareholders' shareholdings of Edelteq for the financial year ending Dec 31, 2025,' it said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Straits Times
5 hours ago
- New Straits Times
Gamuda-PKNPk JV secures Kerian water treatment project from Perak govt
KUALA LUMPUR: Gamuda Bhd, in collaboration with the Perak State Development Corporation (PKNPk), has received a letter of appointment from the Perak state government for the development and operation of water treatment and distribution infrastructure in Kerian. In a filing with Bursa Malaysia today, the engineering and construction group said under the terms of the appointment, the PKNPk-Gamuda joint venture (JV) would carry out the project on a privatisation basis with a minimum 40-year operation period. The scope includes the development and operation of water treatment and distribution infrastructure in the Kerian district, as well as the supply of treated water to the Kerian Integrated Green Industrial Park (KIGIP) and sale of excess treated water to the neighbouring state of Penang. The infrastructure forms part of the broader Northern Perak Water Supply Scheme (NPWSS) which has a total development value of RM5 billion, a strategic initiative by the Perak state and federal governments to address long-standing water shortages for irrigation, domestic and industrial use in the region. "A privatisation agreement is expected to be finalised within 90 days from the date of the JV's appointment to ensure the objective of completing the scheme by 2030 can be achieved," said Gamuda. The development is subject to approval from the relevant regulatory authorities, it said. PKNPk is a statutory body established by the Perak state government in 1967 under the Perak State Development Corporation Enactment No. 3, 1967. It serves as the state's principal agency for driving socioeconomic development and investment. Gamuda said that it would keep Bursa Malaysia Securities Bhd informed of any further material developments. — BERNAMA
Malaysian Reserve
20 hours ago
- Malaysian Reserve
Wise F&I Welcomes Michael Connelly as Vice President, Business Development
ST. LOUIS, July 15, 2025 /PRNewswire/ — Wise F&I, a leading provider of finance and insurance (F&I) products, is proud to formally introduce Michael Connelly in the newest position Vice President of Business Development. Michael joined the organization six months ago and has already made a strong impact with his strategic vision and commitment to delivering tailored support for our agent partners. With over 16 years of industry experience and a bachelor's degree in communications from Boston University, Michael brings both insight and innovation to the role. He first entered the automotive space through a family connection and quickly found his passion—transforming that early start into a meaningful career. Prior to joining Wise F&I, he earned recognition as the 2021 'So You Think You Can F&I' winner during the Ethical F&I Managers Conference, and he continues to be known for his ability to inspire measurable growth within dealerships and agencies alike. Michael's mission is simply to be the most effective partner possible by customizing training, development, and support to the specific needs of each agent. His goals include redefining partnership standards, building strategies for agency growth, and positioning Wise F&I as a trendsetter in an evolving marketplace. According to Jay Sharpnack, Chief Revenue Officer at Wise F&I, 'I've known Connelly for a long time, and he continues to impress me with everything he gets involved in. He hit the ground running and has already become an invaluable asset to both our team and our agent partners. His deep industry knowledge and strong relationship-building skills make him exactly the kind of leader we want driving our business development efforts. Having Mike around really helps Wise Make F&I Fun Again!' Outside of work, Michael enjoys quality time with his family. Whether they're playing games, sharing laughs or playing a round of golf (even though he's admittedly terrible at it). Please join us in welcoming Michael Connelly and celebrating the value he brings to our team and our partners.
The Star
3 days ago
- The Star
BreathDx seeks RM21mil for regional expansion
PETALING JAYA: BreathDx (M) Sdn Bhd, the Malaysian unit of US-based breath diagnostic firm BreathDx Inc, is seeking to raise RM21mil through an offering of Islamic redeemable cumulative convertible preference shares (RCCPS-i) as it prepares to expand operations in Malaysia and the region. The fundraising, facilitated via equity crowdfunding platform AMB Connect, will support the company's efforts to scale up its breath-based diagnostics platform, which uses artificial intelligence and gas chromatography to detect cancer through exhaled breath. 'Being based in Malaysia allows us to look at diseases that often don't get investigated like dengue, Zika or malaria. 'It also gives us an opportunity to localise testing for the region,' said chief executive officer Datuk Rajen Manicka. Of the amount raised, 57% will be allocated toward acquiring machines, research and development (R&D), regulatory compliance, staffing and reimbursements, while the remaining has been earmarked for working capital. The RCCPS-i shares would be issued at RM1 each, with proceeds to be fully utilised within 18 months. To support long-term scalability, BreathDx has outlined a three-pronged revenue strategy: leasing diagnostic machines to point-of-care providers such as hospitals and clinics, charging on a per-test basis, and monetising clinical data for third-party use. 'We are building a model that removes upfront cost barriers for healthcare providers while creating recurring income from both diagnostics and data,' Rajen said. As part of its expansion, the company is also exploring the setting up of a manufacturing plant in Sama Jaya, Sarawak. Rajen said the facility would allow the company to localise production, reduce reliance on China-based manufacturing, and mitigate the impact of tariffs in key export markets such as the United States. The company, recently valued at US$332mil by Valuing IP Sdn Bhd, may also consider a Nasdaq listing within the next two to three years. Rajen added that the valuation could rise further with the completion of clinical studies at Harvard and the US Veterans Administration, approvals from the US Food and Drug Administration and Malaysian regulators, international market entry into Europe, India and North Asia, and local manufacturing in Sarawak. BreathDx has invested more than US$25mil in R&D of micro gas chromatography and holds 25 international patents.
